![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C30H34FN3O2 |
Molar mass | 487.619 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
DPI-3290 was discovered by scientists at Burroughs Wellcome and licensed to Delta Pharmaceutical [1] and is a drug that is used in scientific research. It is a potent analgesic drug,[2] which produces little respiratory depression.[3]
DPI-3290 acts as an agonist at both μ- and δ-opioid receptor, with an IC50 of 6.2nM at μ and 1.0nM at δ.[4]
| |
---|---|
Simple piperazines (no additional rings) |
|
Phenylpiperazines |
|
Benzylpiperazines |
|
Diphenylalkylpiperazines (benzhydrylalkylpiperazines) |
|
Pyrimidinylpiperazines |
|
Pyridinylpiperazines |
|
Benzo(iso)thiazolylpiperazines |
|
Tricyclics (piperazine attached via side chain) |
|
Others/Uncategorized |
|